✦ LIBER ✦

644Palliative radiotherapy in the patients with brain metastases: A randomized study of two different schedules of fractionation and dose of radiotherapy

✍ Scribed by A. Aydin; M. Esassolak; B. Baltalarli; Z. Özsaran; Y. Anacak; N. Demirbaag; F. Göçen; S. Özkök; A. Karahan; A. Haydaroglu

Book ID: 119521720
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 105 KB
Volume: 40
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(96)80653-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

241Palliative radiotherapy in the patien

241Palliative radiotherapy in the patients with bone metastases: A randomized study of different schedules of fractionation and doses of radiotherapy

✍ Özsaran, Z.; Essassolak, M.; Baltalarli, B.; Aydin, A.; African, A.; Yalman, D.; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 112 KB

The responsivness of bone metastases in

The responsivness of bone metastases in breast cancer patients to radiotherapy: prospective study comparing six different fractionation schedules

✍ Borojević, N.; Golubičić, I.; Radošević-Jelić, Lj. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 157 KB

A prospective, randomized study to compa

A prospective, randomized study to compare the value of two fractionation schedules of palliative radiotherapy (RT) for inoperable non-small cell lung cancer (NSCLC)

✍ E. Senkus-Konefka; J. Jassem; E. Bednaruk-Mlynski; R. Dziadziuszko; J. Kubrak; A 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

422 poster The responsiveness of bone me

422 poster The responsiveness of bone metastases in breast cancer patients to radiotherapy with six fractionation schedules

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Evaluation of 2 whole-brain radiotherapy

Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients

✍ Dirk Rades; Radka Lohynska; Theo Veninga; Lukas J. A. Stalpers; Steven E. Schild 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract ## BACKGROUND The majority of breast cancer patients with brain metastases receive whole‐brain radiotherapy (WBRT) and have a survival of only a few months. A short WBRT regimen would be preferable if it provides survival that is similar to that achieved with longer programs. This retr

Zoledronic acid concurrent with either h

Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study

✍ Lale Atahan; Ferah Yıldız; Mustafa Cengiz; Bunyamin Kaplan; Metin Özkan; Gozde Y 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 349 KB